Development of implantable antitumor devices based on polyphosphazenes
- 1 June 1988
- journal article
- Published by Wiley in Makromolekulare Chemie. Macromolecular Symposia
- Vol. 19 (1) , 341-365
- https://doi.org/10.1002/masy.19880190127
Abstract
No abstract availableFunding Information
- Wellcome BV, the Netherlands
This publication has 22 references indexed in Scilit:
- Studies on a bioerodible drug carrier system based on a polyphosphazeneJournal of Controlled Release, 1986
- in vitro studies with melphalan and pediatric neoplastic and normal bone marrow cellsInternational Journal of Cancer, 1986
- Aspects of the stability of isoindoles derived from the reaction of o-phthalaldehyde—ethanethiol with primary amino compoundsJournal of Pharmaceutical and Biomedical Analysis, 1986
- Regional chemotherapy of neoplastic diseasesPharmacology & Therapeutics, 1983
- Cellular pharmacokinetics of the phenylalanine mustardsPharmacology & Therapeutics, 1983
- Degradation of Melphalan in Aqueous Solutions—Influence of Human Albumin BindingJournal of Pharmaceutical Sciences, 1982
- Hydrolysis pathways for aminophosphazenesInorganic Chemistry, 1982
- Controlled synthesis of organic-inorganic polymers that possess a backbone of phosphorus and nitrogen atomsDie Makromolekulare Chemie, 1981
- The influence of pulsation on the dissolution rate measurements in column type apparatusJournal of Pharmacy and Pharmacology, 1970
- In Vitro Assessment of Dissolution Kinetics: Description and Evaluation of a Column-type MethodJournal of Pharmaceutical Sciences, 1969